Journal of Child and Adolescent Psychopharmacology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Letter to the Editor: Suicide Risk Screening Practices in Youth with Developmental Disabilities
Journal of Child and Adolescent Psychopharmacology,Volume 34, Issue 2, Page 108-109, March 2024. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - March 14, 2024 Category: Pediatrics Authors: Jennifer Yoffe Maria Valicenti-McDermott Rosa Seijo Source Type: research

Guanfacine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents with Down Syndrome: A Retrospective Chart Review
Journal of Child and Adolescent Psychopharmacology,Volume 34, Issue 2, Page 95-103, March 2024. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - March 14, 2024 Category: Pediatrics Authors: James H. Powers Michael Wu Michelle Palumbo Christopher J. Keary Christopher J. McDougle Caitlin Ravichandran Robyn P. Thom Source Type: research

Suicide, Stimulants, and Selective Serotonin Reuptake Inhibitors: A Retrospective Chart Review
Journal of Child and Adolescent Psychopharmacology,Volume 34, Issue 2, Page 89-94, March 2024. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - March 14, 2024 Category: Pediatrics Authors: Reena Thomas Austin Sellers Jamie L. Fierstein Mark Cavitt Jeffrey Alvaro Neil Goldenberg Source Type: research

Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation Antipsychotics
Journal of Child and Adolescent Psychopharmacology, Ahead of Print. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - February 26, 2024 Category: Pediatrics Authors: Ning Lyu Paul J. Rowan Susan Abughosh Tyler J. Varisco Ying Lin Hua Chen Source Type: research

Correction to: Machine Learning Identifies Smartwatch-Based Physiological Biomarker for Predicting Disruptive Behavior in Children: A Feasibility Study, by Romanowicz et al. J Child Adolesc Psychopharmacol 2023;33(9):387 –392; doi: 10.1089/cap.2023.0038
Journal of Child and Adolescent Psychopharmacology, Ahead of Print. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - February 19, 2024 Category: Pediatrics Source Type: research

Stimulant Patterns, Alone or with Other Psychotropic Classes, in Medicaid-Insured Youth Continuously Enrolled for 3 –8 Years
Journal of Child and Adolescent Psychopharmacology, Ahead of Print. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - February 16, 2024 Category: Pediatrics Authors: Daniel Zhu Julie M. Zito James F. Gardner Heather A. Young Scott Quinlan Angelo Elmi Source Type: research

Letter to the Editor: The Impact of Adherence and CYP2C19 Phenotype on Escitalopram Exposure in Adolescents
Journal of Child and Adolescent Psychopharmacology,Volume 34, Issue 1, Page 67-69, February 2024. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - February 14, 2024 Category: Pediatrics Authors: W. Thomas Baumel Ethan A. Poweleit Zoe Neptune Heidi K. Schroeder Laura B. Ramsey Jeffrey Mills Jeffrey R. Strawn Source Type: research

Pharmacogenetics and Oxcarbazepine in Children and Adolescents: Beyond HLA-B*15:02
Journal of Child and Adolescent Psychopharmacology,Volume 34, Issue 1, Page 61-66, February 2024. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - February 14, 2024 Category: Pediatrics Authors: Stephani L. Stancil Tracy Sandritter Jeffrey R. Strawn Source Type: research

Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting
Journal of Child and Adolescent Psychopharmacology,Volume 34, Issue 1, Page 52-60, February 2024. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - February 14, 2024 Category: Pediatrics Authors: Erica Tonti Yee Ming Lee Nathan Gruenke Janie Ferren Danielle L. Stutzman Source Type: research

Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study
Journal of Child and Adolescent Psychopharmacology,Volume 34, Issue 1, Page 42-51, February 2024. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - February 14, 2024 Category: Pediatrics Authors: Duncan C. Honeycutt Thomas J. Blom Laura B. Ramsey Jeffrey R. Strawn Kaitlyn M. Bruns Jeffrey A. Welge Luis R. Patino Manpreet K. Singh Melissa P. DelBello Source Type: research

Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents
Journal of Child and Adolescent Psychopharmacology,Volume 34, Issue 1, Page 34-41, February 2024. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - February 14, 2024 Category: Pediatrics Authors: Amarachi A. Kanu Michelle M. Johnston Ethan A. Poweleit Samuel E. Vaughn Jeffrey R. Strawn Laura B. Ramsey Source Type: research

High Probability of Gene-Drug Interactions Associated with Medication Side Effects in Adolescent Depression: Results from a Randomized Controlled Trial of Pharmacogenetic Testing
Journal of Child and Adolescent Psychopharmacology,Volume 34, Issue 1, Page 28-33, February 2024. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - February 14, 2024 Category: Pediatrics Authors: Sara Nooraeen Paul E. Croarkin Jennifer R. Geske Julia Shekunov Scott S. Orth Magdalena Romanowicz Mark A. Frye Jennifer L. Vande Voort Source Type: research

Impact of Cytochrome P450 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects Among Children and Adolescents Treated with Fluoxetine
Journal of Child and Adolescent Psychopharmacology,Volume 34, Issue 1, Page 21-27, February 2024. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - February 14, 2024 Category: Pediatrics Authors: Kanika Bharthi Rayyan Zuberi Abdullah Al Maruf Sarker M. Shaheen Ryden McCloud Madison Heintz Laina McAusland Paul D. Arnold Chad A. Bousman Source Type: research

Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications
Journal of Child and Adolescent Psychopharmacology,Volume 34, Issue 1, Page 4-20, February 2024. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - February 14, 2024 Category: Pediatrics Authors: Salma Malik Pragya Verma Gualberto Rua ño Areej Al Siaghy Azwa Dilawar Jeffrey R. Bishop Jeffrey R. Strawn Lisa B. Namerow Source Type: research

The Pharmacogenetic Journey in Child and Adolescent Psychopharmacology: Are We There Yet?
Journal of Child and Adolescent Psychopharmacology,Volume 34, Issue 1, Page 1-3, February 2024. (Source: Journal of Child and Adolescent Psychopharmacology)
Source: Journal of Child and Adolescent Psychopharmacology - February 14, 2024 Category: Pediatrics Authors: Lisa B. Namerow Jeffrey R. Strawn Source Type: research